235 related articles for article (PubMed ID: 21963854)
1. The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription.
Hsu CH; Peng KL; Jhang HC; Lin CH; Wu SY; Chiang CM; Lee SC; Yu WC; Juan LJ
Oncogene; 2012 May; 31(18):2335-49. PubMed ID: 21963854
[TBL] [Abstract][Full Text] [Related]
2. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation.
Razani B; Altschuler Y; Zhu L; Pestell RG; Mostov KE; Lisanti MP
Biochemistry; 2000 Nov; 39(45):13916-24. PubMed ID: 11076533
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3.
Kumar A; Zhao Y; Meng G; Zeng M; Srinivasan S; Delmolino LM; Gao Q; Dimri G; Weber GF; Wazer DE; Band H; Band V
Mol Cell Biol; 2002 Aug; 22(16):5801-12. PubMed ID: 12138191
[TBL] [Abstract][Full Text] [Related]
4. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300.
Zimmermann H; Degenkolbe R; Bernard HU; O'Connor MJ
J Virol; 1999 Aug; 73(8):6209-19. PubMed ID: 10400710
[TBL] [Abstract][Full Text] [Related]
5. The human papillomavirus E6 oncogene represses a cell adhesion pathway and disrupts focal adhesion through degradation of TAp63β upon transformation.
Ben Khalifa Y; Teissier S; Tan MK; Phan QT; Daynac M; Wong WQ; Thierry F
PLoS Pathog; 2011 Sep; 7(9):e1002256. PubMed ID: 21980285
[TBL] [Abstract][Full Text] [Related]
6. Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients.
Chen SP; Hsu NY; Wu JY; Chen CY; Chou MC; Lee H; Cheng YW
Ann Thorac Surg; 2013 Apr; 95(4):1196-203. PubMed ID: 23522190
[TBL] [Abstract][Full Text] [Related]
7. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity.
Thatte J; Banks L
J Virol; 2017 Nov; 91(22):. PubMed ID: 28835500
[TBL] [Abstract][Full Text] [Related]
8. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
9. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
[TBL] [Abstract][Full Text] [Related]
10. Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth.
Pim D; Massimi P; Banks L
Oncogene; 1997 Jul; 15(3):257-64. PubMed ID: 9233760
[TBL] [Abstract][Full Text] [Related]
11. Protein-arginine methyltransferase 1 (PRMT1) methylates Ash2L, a shared component of mammalian histone H3K4 methyltransferase complexes.
Butler JS; Zurita-Lopez CI; Clarke SG; Bedford MT; Dent SY
J Biol Chem; 2011 Apr; 286(14):12234-44. PubMed ID: 21285357
[TBL] [Abstract][Full Text] [Related]
12. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
Thomas MC; Chiang CM
Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
[TBL] [Abstract][Full Text] [Related]
13. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol and Pterostilbene Exhibit Anticancer Properties Involving the Downregulation of HPV Oncoprotein E6 in Cervical Cancer Cells.
Chatterjee K; AlSharif D; Mazza C; Syar P; Al Sharif M; Fata JE
Nutrients; 2018 Feb; 10(2):. PubMed ID: 29485619
[TBL] [Abstract][Full Text] [Related]
15. Activating transcription factor 3 activates p53 by preventing E6-associated protein from binding to E6.
Wang H; Mo P; Ren S; Yan C
J Biol Chem; 2010 Apr; 285(17):13201-10. PubMed ID: 20167600
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of p53 rescues the maintenance of high risk HPV DNA genomes deficient in expression of E6.
Lorenz LD; Rivera Cardona J; Lambert PF
PLoS Pathog; 2013 Oct; 9(10):e1003717. PubMed ID: 24204267
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of HeLa cells is a conserved feature of high-risk human papillomavirus E8^E2C proteins and can also be achieved by an artificial repressor protein.
Fertey J; Hurst J; Straub E; Schenker A; Iftner T; Stubenrauch F
J Virol; 2011 Mar; 85(6):2918-26. PubMed ID: 21191025
[TBL] [Abstract][Full Text] [Related]
18. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53.
DasGupta T; Nweze EI; Yue H; Wang L; Jin J; Ghosh SK; Kawsar HI; Zender C; Androphy EJ; Weinberg A; McCormick TS; Jin G
Oncotarget; 2016 May; 7(19):27430-44. PubMed ID: 27034006
[TBL] [Abstract][Full Text] [Related]
20. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]